:

Contract Award: DMS Pharmaceutical Group Inc. (Parkridge, Illinois) – $197,389,402

Defense Daily Staff

Thursday, October 10th, 2024

SHARE:

DMS Pharmaceutical Group Inc.,** Parkridge, Illinois, has been awarded an estimated $197,389,402 modification (P00021) extending the third two-year six-month option period of a two-year six-month base contract (SPE2DX-15-D-9000) with three two-year six-month option periods for prime vendor pharmaceutical and pharmaceutical-related products and support. This is a firm-fixed-price, requirements contract. Locations of performance are inside and outside the continental U.S., with a Nov. 12, 2025, performance completion date. Type of appropriation is fiscal 2025 through 2026 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania. (Awarded Oct. 8, 2024)

Congress

Key Defense Committee Members Face Tight Midterm Races, Including HASC GOP’ers In Virginia

As the mid-term elections near with polls showing an increasing likelihood of a switch in majority control in the House and potentially the Senate, three Virginia Republicans on the House […]

‘Theoretical Potential’ to Achieve 1,509 Combat-Coded Fighters by 2035, USAF Says

In the latest U.S. Air Force fighter force structure report submitted to Congress, the service speaks of a “theoretical potential” to achieve a goal of 1,509 combat-coded fighters in the […]

Budget

Hegseth Pushes For Reconciliation With At Least $350 Billion For Defense ‘Regardless’ Of Midterms Outcome

Defense Secretary Pete Hegseth said Wednesday the Trump administration plans to continue its push for at least $350 billion in defense funds via the reconciliation process “regardless of what happens […]

Congress

Bipartisan Push in Senate to Hasten Export of 155 mm, GMLRS, HIMARS for Ukraine

A small, bipartisan group of senators is backing the Fast Tracking European Investment in Ukraine’s Defense Act, S. 5175, to hasten the export of allied buys of U.S. munitions for […]